Cargando…
The expression of survivin in irreversible pulmonary arterial hypertension rats and its value in evaluating the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
The reversibility of pulmonary arterial hypertension (PAH) determines the operability of congenital heart disease (CHD) complicating with PAH, but it lacks a method for evaluating the reversibility. The current study aims to investigate the serum survivin level in irreversible PAH rats and to explor...
Autores principales: | Li, Gang, Zhang, Han, Zhao, Lei, Zhang, Yaozhong, Yan, Daole, Liu, Yinglong, Su, Junwu, Fan, Xiangming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681502/ https://www.ncbi.nlm.nih.gov/pubmed/31428312 http://dx.doi.org/10.1177/2045894019859480 |
Ejemplares similares
-
Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
por: Blanco, Isabel, et al.
Publicado: (2023) -
Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
por: Huang, Li, et al.
Publicado: (2018) -
Potential biomarkers and targets in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study
por: Huang, Li, et al.
Publicado: (2018) -
Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019) -
The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax
por: Jacheć, Wojciech, et al.
Publicado: (2019)